Willamette Valley Cancer Institute and Research Center — Eugene, Oregon

Willamette Valley Cancer Institute and Research Center is a clinical research site located in Eugene, Oregon, United States 97401.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Willamette Valley Cancer Institute and Research Center has participated in 46 clinical trials with 16 currently active.

Therapeutic areas: Metastatic Pancreatic Cancer, High Grade Serous Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Infinity Pharmaceuticals, Inc., Mersana Therapeutics, Pfizer.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Willamette Valley Cancer Institute and Research Center?

Willamette Valley Cancer Institute and Research Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Willamette Valley Cancer Institute and Research Center conducted?

Willamette Valley Cancer Institute and Research Center has 46 clinical trials on record, with 16 currently active. Their work covers Metastatic Pancreatic Cancer, High Grade Serous Ovarian Cancer, Fallopian Tube Cancer.

Is Willamette Valley Cancer Institute and Research Center accredited by Crixeo Health?

Yes — Willamette Valley Cancer Institute and Research Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Willamette Valley Cancer Institute and Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.